You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / ASTRAZENECA PHARMA INDIA

ASTRAZENECA PHARMA INDIA
Intrinsic Value | Fundamental Analysis

Returns | 1W : 22.6% , 1M : 35%,1Y : 49.6%
BOM : 506820     NSE : ASTRAZEN    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Apr 22,2021
Price(EOD): Rs. 4,293.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 10,733.25 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
ASTRAZENECA PHARMA INDIA 22.6% 35% 49.6%
SUN PHARMACEUTICAL INDUSTRIES 1.2% 11.4% 36.3%
DR REDDYS LABORATORIES 7.4% 23.5% 34.1%
DIVIS LABORATORIES -0.8% 14.8% 61.7%
CIPLA 3.3% 25.1% 62.3%
BIOCON -1.2% 2.6% 12.1%
AUROBINDO PHARMA 8.6% 23.1% 82.7%
LUPIN 1.1% 6.1% 34.7%
TORRENT PHARMACEUTICALS 0.4% 8.8% 11.6%

FUNDAMENTAL ANALYSIS OF ASTRAZENECA PHARMA INDIA

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than ASTRAZENECA PHARMA INDIA Premium


VALUATION OF ASTRAZENECA PHARMA INDIA

 
Valuation Score
RatioValue
P/E
P/B
P/S
148.66
P/E Calculated based on EPS of 28.88
[ Mar2020 - Standalone Results ]

29.58
P/B Calculated based on Book Value of 145.14
[ Mar2020 - Standalone Results ]

13.08
P/S Calculated based on Revenues of 820.825 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than ASTRAZENECA PHARMA INDIA Premium


FAIR VALUE OF ASTRAZENECA PHARMA INDIA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
128%
145%
141%

SHARE PRICE MOMENTUM OF ASTRAZENECA PHARMA INDIA

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0
0
-
-
-
-
-
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
-4.4%
-16.8%
-20.44%
-20.07%
-10.55%
-16.29%
-19.56%
-21.16%
QtrlyTrend
-8
Latest Qtr: Dec2020

ASTRAZENECA PHARMA INDIA related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 3.7% 15.3% 56.9%
S&P BSE SMALL CAP 0.5% 2.5% 90.8%
S&P BSE MIDSMALLCAP 0.2% 1.7% 80%
S&P BSE 150 MIDCAP 0.1% 1.4% 78.1%
S&P BSE 400 MIDSMALLCAP 0% 1% 81%
S&P BSE ALLCAP -0.8% -0.3% 59.7%
S&P BSE 500 -0.9% -0.4% 58.8%
S&P BSE 250 LARGEMIDCAP -0.9% -0.4% 57.2%
NSE Indices1W1M1Y
NIFTY MID SMALL400 -0.1% 0.9% 80.8%
NIFTY MIDCAP150 -0.3% 0.9% 76.5%
NIFTY 500 -0.9% -0.4% 58.3%
NIFTY LARGE MIDCAP 250 -0.9% -1.7% 65%

FAQ [Frequently Asked Questions]


Is ASTRAZEN good for long term investment?

As on 22-Apr-2021, the Fundamentals of ASTRAZEN are Strong and hence it's good for long term investment! See Financial Performance of ASTRAZENECA PHARMA INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is ASTRAZEN UnderValued or OverValued?

As on 22-Apr-2021, ASTRAZEN is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of ASTRAZEN ?

As on 22-Apr-2021, the Intrinsic Value of ASTRAZEN is Rs. 1,779.55 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,882.39
Fair Value [Median EV / Sales Model] : Rs. 1,752.82
Fair Value [Median Price / Sales Model] : Rs. 1,779.55
Median Fair Value of ASTRAZEN : Rs. 1,779.55

Is ASTRAZEN trading at a Premium or Discount?

As on 22-Apr-2021, ASTRAZEN is trading at a Premium of 141% based on the Median Intrinsic Value!

Is it right time to buy ASTRAZEN shares?

As on 22-Apr-2021, ASTRAZEN is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of ASTRAZEN?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with ASTRAZEN?

ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
ASTRAZENECA PHARMA INDIA LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z